Apolipoprotein A-I as a Molecular Target of the Immunomodulatory Peptide Jusvinza: Mechanistic Insights From Affinity and In Silico Studies
{{output}}
Jusvinza is an immunomodulatory pharmaceutical drug developed for the treatment of rheumatoid arthritis. Its active ingredient is an altered peptide ligand-derived from a T-cell epitope of the human 60-kDa heat shock protein-referred to as CIGB-814. Jusvinza h... ...
